Research and Development
CreaGen’s discovery research services currently supports several disease areas including metabolic syndrome, specifically Type II diabetes, infection, inflammation, CNS, neurodegeneration and oncology. Current programs encompass these important target classes that represent 70% of the drugs currently on the market.

CreaGen Team is constantly involved in developing novel preclinical candidates for our partners in the following areas:

• Synthetic small molecules and
• Natural Products

For more information
Please contact our R & D Coordinator
 
News
  CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/ https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO   more...
    7th Advances In Chemical Sciences Symposium: May 4th, 2018
The Seventh Annual Advances in Chemical Sciences Symposium Royal Sonesta Hotel Cambridge, MA: May 4th, 2018 A day-long symposium focused on Medicinal Chemistry, Organic Synthesis, and Methodology, featuring eminent scientists from industry and academia. Speakers: Professor Richard R. Schrock (MIT): “TBA” Professor Dale L. Boger (Scripps Research Institute): “Redesign of Vancomycin for Resistant Bacteria” Professor Laura Kiessling (MIT): “TBA” Dr. Sue Ashwell (Forma Therapeutics): “Discovery and Optimization of a Novel Series of Inhibitors of mt-IDH1” Dr. Michael Hoemann (Abbvie): “Discovery and Optimization of Spleen Tyrosine Kinase Inhibitors for Immunological Diseases” Dr. Frank Salituro (Sage Therapeutics): “Discovery and Clinical Development of SAGE-217: A Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (GABA)A Receptor” Plus: Vendor Exhibition Hall and Networking Reception   more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.